Expedited PublicationsIntracoronary Compared With Intravenous Bolus Abciximab Application During Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: Cardiac Magnetic Resonance Substudy of the AIDA STEMI Trial
Under an Elsevier user license
open archive
Key Words
angioplasty
cardiac magnetic resonance imaging
glycoprotein IIb/IIIa inhibition
infarction
infarct size
Abbreviations and Acronyms
CMR
cardiac magnetic resonance
IQR
interquartile range
LV
left ventricular
MACE
major adverse cardiac event(s)
MO
microvascular obstruction
PCI
percutaneous coronary intervention
STEMI
ST-segment elevation myocardial infarction
Cited by (0)
This study was funded by the University of Leipzig-Heart Centre and the University of Leipzig, Clinical Trial Centre Leipzig, which is supported by the Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) FKZ 01KN1102. Dr. Thiele is a consultant to Eli Lilly & Company and Maquet Cardiovascular; and receives research funding from Eli Lilly & Company, Terumo, Maquet Cardiovascular, and Teleflex Medical. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.